-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
smpdl3b
-
A novel estrogen receptor 1: sphingomyelin phosphodiesterase acid-like 3B pathway mediates rituximab response in myositis patients, 2022, Parkes et al
A novel estrogen receptor 1: sphingomyelin phosphodiesterase acid-like 3B pathway mediates rituximab response in myositis patients Parkes, Joanna E; Boehler, Jessica F; Li, Ning; Kendra, Ryan M; O’Hanlon, Terrance P; Hoffman, Eric P; Peterson, Jennifer M; Miller, Frederick W; Rider, Lisa G...- SNT Gatchaman
- Thread
- autoimmune disease estrogen micro-rna myositis rituximab smpdl3b sphingomyelin
- Replies: 1
- Forum: Other health news and research
-
2023 IIMEC15 - Alain Moreau
YouTube: IIMEC15 07 Professor Alain Moreau 15th Invest in ME Research International ME Conference 2023 Discussion of potential biomarkers in ME/LC subgroups. References upcoming, unpublished work. Highlighted time-stamps — 9:07 MicroRNAs 18:18 SMPDL3B 27:03 FGF-21 SMPDL3B is Sphingomyelin...- SNT Gatchaman
- Thread
- biomarker fgf21 micro-rna moreau smpdl3b
- Replies: 21
- Forum: ME/CFS research news